Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years' Use of Infliximab for Rheumatoid Arthritis

Intern Med. 2023 Jan 1;62(1):81-85. doi: 10.2169/internalmedicine.9059-21. Epub 2022 May 31.

Abstract

A 43-year-old Japanese woman with rheumatoid arthritis treated by infliximab and methotrexate for 11 years was admitted for proteinuria and purpura. A kidney biopsy revealed endothelial damage-dominant nephritis with IgA deposition. Infliximab and methotrexate were discontinued, and tocilizumab was started; however, proteinuria persisted. Therefore, tocilizumab was discontinued, and oral prednisolone and methylprednisolone pulse therapy were administered. After 6 months, urinary protein was less than 0.1 g/day, and purpura subsided. To our knowledge, this is the first case of endothelial damage-dominant nephritis related to IgA vasculitis involving the skin and kidney after long-term use of infliximab and methotrexate.

Keywords: IgA vasculitis; endocapillary glomerulonephritis; rheumatoid arthritis; tocilizumab.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Arthritis, Rheumatoid* / complications
  • Arthritis, Rheumatoid* / drug therapy
  • Female
  • Humans
  • IgA Vasculitis* / complications
  • IgA Vasculitis* / drug therapy
  • Infliximab / adverse effects
  • Methotrexate
  • Nephritis*
  • Proteinuria
  • Purpura*

Substances

  • Infliximab
  • Methotrexate